Ranitidine
Formulations: - Oral > Liquid: 75 mg per 5 mL (as hydrochloride) Oral > Solid: 150 mg (as hydrochloride) Parenteral > General injections > unspecified: 25 mg per mL in 2 mL ampoule (as hydrochloride) Indications: - Peptic ulcer, site unspecified - Gastro-oesophageal reflux disease Source: EML workbook import
